Denmark -
Denmark -
Lægemiddelstyrelsen (Danish Medicines Agency)
elvanse 60 mg kapsler, hårde
takeda pharmaceuticals international ag ireland branch - lisdexamfetamindimesilat - kapsler, hårde - 60 mg
Denmark -
Denmark -
Lægemiddelstyrelsen (Danish Medicines Agency)
elvanse 70 mg kapsler, hårde
takeda pharmaceuticals international ag ireland branch - lisdexamfetamindimesilat - kapsler, hårde - 70 mg
Kesatuan Eropah -
Denmark -
EMA (European Medicines Agency)
resolor
takeda pharmaceuticals international ag ireland - prucalopride tocopherolsuccinat hidrørende - forstoppelse - andre stoffer til forstoppelse - resolor er indiceret til symptomatisk behandling af kronisk forstoppelse hos voksne, hvor afføringsmidler ikke giver tilstrækkelig lindring.
Denmark -
Denmark -
Lægemiddelstyrelsen (Danish Medicines Agency)
equasym depot 20 mg kapsler med modificeret udløsning, hårde
takeda pharmaceuticals international ag ireland branch - methylphenidathydrochlorid - kapsler med modificeret udløsning, hårde - 20 mg
Denmark -
Denmark -
Lægemiddelstyrelsen (Danish Medicines Agency)
equasym depot 30 mg kapsler med modificeret udløsning, hårde
takeda pharmaceuticals international ag ireland branch - methylphenidathydrochlorid - kapsler med modificeret udløsning, hårde - 30 mg
Kesatuan Eropah -
Denmark -
EMA (European Medicines Agency)
advagraf
astellas pharma europe bv - tacrolimus - graft afvisning - immunosuppressiva - profylakse af transplantationsafstødning hos voksne nyre- eller levertransplantationsmodtagere. behandling af allograft afvisning resistente over for behandling med andre immunosuppressive lægemidler hos voksne patienter.
Kesatuan Eropah -
Denmark -
EMA (European Medicines Agency)
modigraf
astellas pharma europe b.v. - tacrolimus - graft afvisning - immunosuppressiva - profylakse af transplantatafstødning hos voksne og pædiatriske, nyre-, lever- eller hjerte-allograftmodtagere. behandling af allograft rejection resistente over for behandling med andre immunsuppressive lægemidler hos voksne og pædiatriske patienter.
Kesatuan Eropah -
Denmark -
EMA (European Medicines Agency)
ximluci
stada arzneimittel ag - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologiske - ximluci is indicated in adults for:the treatment of neovascular (wet) age-related macular degeneration (amd)the treatment of visual impairment due to diabetic macular oedema (dme)the treatment of proliferative diabetic retinopathy (pdr)the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)the treatment of visual impairment due to choroidal neovascularisation (cnv).
Kesatuan Eropah -
Denmark -
EMA (European Medicines Agency)
ranivisio
midas pharma gmbh - ranibizumab - wet macular degeneration; macular edema; diabetic retinopathy; diabetes complications - oftalmologiske - ranivisio is indicated in adults for:• the treatment of neovascular (wet) age-related macular degeneration (amd)• the treatment of visual impairment due to diabetic macular oedema (dme)• the treatment of proliferative diabetic retinopathy (pdr)• the treatment of visual impairment due to macular oedema secondary to retinal vein occlusion (branch rvo or central rvo)• the treatment of visual impairment due to choroidal neovascularisation (cnv).
Denmark -
Denmark -
Lægemiddelstyrelsen (Danish Medicines Agency)
alkeran 2 mg filmovertrukne tabletter
aspen pharma trading limited - melphalan - filmovertrukne tabletter - 2 mg